Search Results - "A. L. Kurenkov"

Refine Results
  1. 1

    Managing Digital Transformation Projects: Current Trends and Characteristics by Kurenkov, A. L.

    “…Digital transformation is an integral part of strategic management at the commercial enterprise, which ensures its sustainable development and competitiveness…”
    Get full text
    Journal Article
  2. 2

    Assessment of spasticity-related pain in cerebral palsy and the efficacy of its treatment with incobotulinumtoxin A (literature review) by Kurenkov, A. L., Bursagova, B. I., Artemenko, A. R.

    “…Pain in cerebral palsy (CP) occurs in 30–60% of cases. Pain associated with spasticity (PAS) is one of the most common causes of pain syndrome in cerebral…”
    Get full text
    Journal Article
  3. 3

    Effects of topiramate on migraine frequency and cortical excitability in patients with frequent migraine by Artemenko, A R, Kurenkov, A L, Filatova, E G, Nikitin, S S, Kaube, H, Katsarava, Z

    Published in Cephalalgia (01-03-2008)
    “…We studied the excitability of the visual and motor cortex in 36 patients with frequent migraine without aura (30 women, mean age 38.6 +/- 10.0 years) before…”
    Get more information
    Journal Article
  4. 4

    Priorities and Goals of Botulinum Toxin A Treatment in Cerebral Palsy by Klochkova, O A, Kurenkov, A L

    “…Botulinum toxin A (BTA) injections are an effective method of spasticity treatment in cerebral palsy (CP) but still there are a lot of questions about the…”
    Get more information
    Journal Article
  5. 5

    IncobotulinumtoxinA in the treatment of sialorrhea in patients with infantile cerebral palsy by Kurenkov, A. L., Kuzenkova, L. M., Chernikov, V. V., Bursagova, B. I., Nezhelskaya, A. A., Artemenko, A. R.

    “…Sialorrhea is a severe medical problem that is difficult to treat, which can lead to serious complications. In almost all cases, chronic sialorrhea is…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Treatment of spasticity after traumatic brain injury in children: the role of botulinum toxin therapy by Klochkova, O A, Kurenkov, A L, Mamontova, N A

    “…Traumatic brain injury (TBI) is one of the main reasons of death and disability in children and adolescents in Russia and abroad. Spasticity is a frequent…”
    Get more information
    Journal Article
  8. 8
  9. 9

    EXPERIENCE OF THE TYPE A BOTULINUM TOXIN TYPE (ONABOTULINUMTOXINA) DRUG IN TREATMENT OF CEREBRAL PALSY PATIENTS by A. L. Kurenkov, O. A. Klochkova, B. I. Bursagova, L. M. Kuzenkova, A. R. Artemenko, I. V. Falkovsky

    Published in Medicinskij sovet (01-12-2017)
    “…Injections of botulinum toxin type A (BTA) are regarded as one of the basic methods to treat cerebral palsy (CP). The article discusses issues unique mechanism…”
    Get full text
    Journal Article
  10. 10

    MEROSIN-DEFICIENT CONGENITAL MUSCULAR DYSTROPHY (CMD1A): CLINICAL CASE OF CONGENITAL MUSCULAR DYSTROPHY INVOLVING CENTRAL NERVOUS SYSTEM by Klochkova, O. A., Kurenkov, A. L., Mamed'yarov, A. M.

    “…Congenital muscular dystrophies (CMDs) are an extremely heterogenous group of neuromuscular diseases. The article presents the general information on clinical…”
    Get full text
    Journal Article
  11. 11

    The functional asymmetry of the facial neuromotor apparatus in patients with facial nerve neuropathy and its treatment with botulinum toxin type A lantox by Saksonova, E V, Orlova, O R, Kurenkov, A L

    “…A clinical and electrophysiological (EMG, ENMG, the blink reflex) examination has been carried out in 85 patients with facial nerve lesions of different…”
    Get more information
    Journal Article
  12. 12

    Development of motor functions and manual abilities in pediatric patients with spastic cerebral palsy after botulinum toxin treatment and complex rehabilitation by Klochkova, O A, Kurenkov, A L, Namazova-Baranova, L S, Mamed'iarov, A M, Zherdev, K V

    “…To investigate the dynamic of general motor function and manual abilities in children with spastic forms of cerebral palsy (CP) after complex rehabilitation…”
    Get more information
    Journal Article
  13. 13
  14. 14

    SPASTICITY PATTERNS OF HAND MUSCLES AND BOTULINUM TOXIN THERAPY APPLICATION IN PATIENTS WITH CEREBRAL PALSY WITH UPPER LIMB INVOLVEMENT by Klochkova, O. A., Kurenkov, A. L., Namazova-Baranova, L. S., Mamedyarov, A. M.

    “…Botulinum toxin therapy is an effective and safe method of treatment of local spasticity in patients with cerebral palsy (CP). Calculation of botulinum toxin A…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    BOTULINUM TOXIN A INJECTION PRECISION CONTROL AT SPASTIC FORMS OF CEREBRAL PALSY: METHODOLOGY CHOICE by Klochkova, O. A., Kurenkov, A. L., Mamed'yarov, A. M., Namazova-Baranova, L. S., Gevorkyan, A. K., Karimova, Kh. M.

    “…The article provides general information on botulinum therapy in treating spastic forms of cerebral palsy; a review of modern botulinum toxin A drugs’…”
    Get full text
    Journal Article
  18. 18

    Duloxetine in the treatment of chronic migraine by Artemenko, A R, Kurenkov, A L, Nikitin, S S, Filatova, E G

    “…The aim of the study was to investigate the influence of duloxetine on clinical parameters and antinociceptive mechanisms in 46 patients with chronic migraine…”
    Get more information
    Journal Article
  19. 19

    An electromyographic study on the development of optimal tactics of botulinum toxin type A injections in children with spastic forms of cerebral palsy by Kurenkov, A L, Kuzenkova, L M, Burgasova, B I, Petrova, S A, Klochkova, O A, Nikitin, S S, Artemenko, A R, Mamed'iarov, A M

    “…We studied 67 children, aged 2-9 years, with cerebral palsy including 56 children with a spastic form. An electromyographic method was used for the development…”
    Get more information
    Journal Article
  20. 20

    Features of epileptiform activity on EEG in children with periventricular leukomalacya and cerebral palsy without epilepsy by Mukhin, K Iu, Kuz'mich, G V, Balkanskaia, S V, Batysheva, T T, Kurenkov, A L, Gorina, T P

    “…We have analyzed morphologic and chronologic characteristics of epileptiform activity, with account for repeated EEG-study during the follow-up, in patients…”
    Get more information
    Journal Article